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Abstract
Background: Iatrogenic injection injury is a major cause of disability in Ugandan children. Two injuries thought to
result from injection of medications into the gluteal region include post-injection paralysis (PIP) and gluteal fibrosis
(GF). This study aimed to describe perceptions of local health care workers regarding risk factors, particularly
injections, for development of GF and PIP. Specifically, we examine the role of injection practices in the
development of these injuries by interviewing a diverse cohort of individuals working in the health sector.
Methods: We conducted a qualitative study in the Kumi and Wakiso Districts of Uganda in November 2017,
utilizing 68 key informant interviews with individuals working in healthcare related fields. Interviews were structured
utilizing a moderator guide focusing on injection practices, gluteal fibrosis and post-injection paralysis.
Results: We identified six themes regarding perceptions of the cause of GF and PIP and organized these themes
into a theoretical framework. There was a consensus among the individuals working in healthcare that inadequacies
of the health care delivery system may lead to inappropriate intramuscular injection practices, which are presumed
to contribute to the development of GF and PIP. Poor access to medications and qualified personnel has led to
the proliferation of private clinics, which are often staffed by under-trained practitioners. Misaligned economic
incentives and a lack of training may also motivate practitioners to administer frequent intramuscular injections,
which cost more than oral medications. A lack of regulatory enforcement enables these practices to persist.
However, due to limited community awareness, patients often perceive these practitioners as appropriately trained,
and the patients frequently prefer injections over alternative treatment modalities.
Conclusion: This qualitative study suggests that inappropriate intramuscular injections, may arise from problems in
the health care delivery system. To prevent the disability of GF and PIP, it is important to not only address the
intramuscular injections practices in Uganda, but also to examine upstream deficits in access, education, and policy
enforcement.
Keywords: Gluteal fibrosis, Post-injection paralysis, Uganda, Injection practices, Safe injection, Pediatric
musculoskeletal health, Pediatric orthopaedics, Intramuscular injection
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Background
Every year an estimated 12 billion injections are per-
formed by health care practitioners [1]. Most injections
given in the developing world are provided using unsafe
practices [2]. Given that many people in resource-limited
countries perceive injections to be more effective than oral
medications, there is a risk that injections can be used
inappropriately by inadequately trained personnel [3–6].
In addition to infectious complications, disabling muscu-
loskeletal conditions including GF and PIP have also been
linked to intramuscular injections. These have been re-
ported to occur throughout the world including Uganda,
where these disabling impairments have become com-
mon health problems in children [4, 7–13]. A recently
performed retrospective cohort study in Kumi, Uganda
demonstrated that GF and PIP comprise over 30% of
clinical hospital visits for musculoskeletal conditions
and 40% of outreach visits for disabling conditions in
Kumi District [14].
Clinically, PIP presents as acute flaccid paralysis and
subsequent chronic acquired equinovarus foot deform-
ities, following a gluteal injection [10, 13]. The strong
temporal association between injection and onset of PIP
points to an etiologic role for injections. However, the
specific injection practices that may contribute to patho-
genesis of PIP remain unknown. GF is a fibrotic contrac-
ture of the gluteal muscles, causing significant functional
limitations While the cause has not been confirmed, GF
has also been attributed to gluteal injections [7]. In one
prior assessment of children with GF in Uganda all
children reported histories of multiple injections, with
quinine involved in 83% of the cases [9]. Given the fre-
quency of these disabilities and the mounting evidence
linking PIP and GF to injections, it is imperative to bet-
ter understand injection practices in Uganda.
The primary aim of the present study was to obtain
qualitative data on perceptions of individuals working in
healthcare related fields regarding local injection practices
and the potential role of these practices in the pathogen-
esis in GF and PIP. A secondary aim was to obtain qualita-
tive data on local knowledge of risk factors for GF and PIP
in Uganda. We compared views on injection practices and
standards of practice among health care workers in both
the northeastern rural Kumi District, a region with a high
burden of GF and PIP, to those from the more central
urban Wakiso District, where these disorders appear to be
less prevalent [14].
Methods
Study design
This study utilized in-depth interviews with 68 healthcare
practitioners to understand perceptions of injection prac-
tices. Interview locations included non-governmental
organization run hospitals, government health centers,
private clinics, public pharmacies and private drug
shops in six subcounties in Kumi District and seven
subcounties in Wakiso District in November 2017.
The contrasting settings of the rural Kumi District
and urban Wakiso District reflect areas of divergent
resources and health care access. One prior study doc-
umented this divergence in resources, citing that55%
of women ages 15–49 in Kumi reported serious prob-
lems in accessing health care in contrast to 13% in
Wakiso [15].
Individuals were considered for inclusion in the
study if they currently worked in healthcare sector,
spoke English, were over 18 years of age, were cur-
rently working/residing in Kumi or Wakiso District,
and were willing to provide written consent. Local ex-
perts in the health care community in Kumi and
Wakiso districts helped to identify persons who met
these criteria. Purposive sampling captured diversity
of gender, age, professional experience, and public
versus private healthcare sector involvement [16]. The
key informants selected were individuals involved in
the healthcare system who, due to the nature of their
work, would likely have knowledge of local injection
practices and who worked in a capacity that poten-
tially exposed them to the two disabilities of interest.
The informants had a range of roles and training,
and included healthcare professionals such as district
health officers, physicians, nurses, local practitioners,
pharmacists, drug shop workers, village health workers,
social workers, and government drug inspectors. “Local
practitioners” refers to health care practitioners working
in the private sector without formal physician training.
“Village health workers” are linked to the formal health
system in Uganda and provide outreach and referral into
the public sector.
Data collection procedures
The lead author (KA) conducted each interview in a
closed room. Each interview was audio-recorded and fa-
cilitated by a local Ugandan research staff member (DA).
All subjects answered a series of demographic questions,
followed by a semi-structured interview regarding their
perceptions of injection practices and underlying causes
of GF and PIP.
We developed the interview guide based on formative
in-country research, information regarding injection
practices, GF and PIP from community leaders, and lit-
erature reviews on GF and PIP. Interview questions
were tested and refined in pilot interviews in-country
to ensure they could be easily understood by partici-
pants. The interviews covered the following topics:
perceptions of injection practices, malaria treatment
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practices, knowledge or personal experience with GF
and PIP, and perceived causes of GF and PIP. The
semi-structured nature of the interviews allowed for
discussion of these topics, as well as inclusion of
participant-led perspectives and discourses. All inter-
views were transcribed, verbatim, for analysis.
Ethical considerations
The study was approved by the Mildmay Uganda Research
Ethics Committee, the Uganda National Council for Sci-
ence and Technology, and the Partners HealthCare Insti-
tutional Review Board at Brigham and Women’s Hospital.
The participants were informed about the purpose of the
study and assured about the confidentiality of information
they provided. Written informed consent was obtained
prior to participation.
Data analysis
Analysis of qualitative transcripts consisted of thematic
content analysis employing both inductive and deductive
approaches [17]. Audio recordings were transcribed verba-
tim, and the Dedoose web application was used for subse-
quent data management. Utilizing a subset of transcripts,
two investigators (KA, AC) developed an initial coding
framework based on emerging concepts [18]. Codes were
defined as repeated concepts, and sub-codes were defined
as categories within the codes. A comprehensive list of
codes was established and all investigators reviewed the re-
fined coding scheme. The coding scheme was re-assessed
at regular intervals in the coding process to ensure the
proper inclusion of any newly emerging ideas. Informal
intercoder reliability assessments were conducted through-
out the coding process to ensure consistency in the applica-
tion of codes across investigators.
Two investigators (KA, AC) employed an inductive
thematic analysis in which themes were extracted from
the coded text to produce inferences and create a con-
ceptual framework [19–21]. Organizing and analyzing
data in this way allowed the research team to identify
perceived connections between: 1) intramuscular injec-
tions practices and GF; 2) intramuscular injections prac-
tices and PIP; and 3) other possible risk factors for GF
and PIP. The analysis was iterative in nature and de-
signed to identify categories and concepts that emerged
within text. Each theme was reviewed to ensure that the
excerpts supported it. We sought to describe the range
of views and key concerns; where considerable differ-
ences in opinions between interviewees were present, we
noted and made such differences explicit. Anonymized
quotations were utilized to support the interpretation of
themes and to highlight the perspectives of the health
care professionals and community leaders interviewed
(Appendix).
Results
Participants
Key informants for this study were 68 individuals, in-
cluding 38 men and 30 women, with ages ranging from
23 to 62 (Table 1). Participants came from 13 subcounties
throughout Kumi and Wakiso District and represented 7
healthcare professions: district health officials (n = 3),
physicians (n = 11), nurses (n = 19), pharmacists/drug
shop workers (n = 12), social workers/community based
workers (n = 5), village health workers (n = 9), and local
community practitioners (n = 9).
All practitioners were asked if they had personally seen
cases of GF and/or PIP. While all 41 participants in Kumi
District had seen both GF and PIP, only 33% (9/27) of
Wakiso participants had first-hand experience with GF
and only 56% (15/27) with PIP. For those Wakiso partici-
pants who did have first-hand experience, most had not
seen the conditions in a long time or saw PIP and GF in
previous work outside of Wakiso.
Thematic analysis – Overview
We identified six themes regarding the perceptions of
the underlying cause of GF and PIP and we organized
these themes into a theoretical framework (Fig. 1).
Across districts, professions and gender, participants
consistently reported a perception that GF and PIP
Table 1 Participant Characteristics
Kumi (41 total) Wakiso (27 total)
No. (%) No. (%)
Gender
Female 18 (43.9) 12 (44.4)
Male 23 (56.1) 15 (55.6)
Age
18–29 12 (29.3) 7 (25.9)
30–44 20 (48.8) 13 (48.1)
45–60 8 (19.5) 7 (25.9)
60+ 1 (2.4) 0 (0)
Profession
District Health Official 2 (4.9) 1 (3.7)
Physician 8 (19.5) 3 (11.1)
Nurse 12 (29.3) 7 (25.9)
Pharmacist/Drug Shop worker 7 (17.1) 5 (18.5)
Local Practitioner 6 (14.6) 3 (11.1)
Village Health Worker 3 (7.3) 6 (22.2)
Other 3 (7.3) 2 (7.4)
Professional Sector
Private 20 (48.8) 12 (44.4)
Public 21 (51.2) 15 (55.6)
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were the result of intramuscular (IM) injections. Further,
the participants attributed administration of these injec-
tions to challenges in the health care delivery system.
Specifically, a lack of accessibility to medications and
qualified personnel resulted in a gap in care that has been
increasingly filled by private clinics. These clinics –
often staffed by untrained personnel and motivated by
misaligned economic incentives, with increased pay for
injections in comparison to oral medications, and a lax
regulatory environment – seem to be a common site of
inappropriate administration of intramuscular injec-
tions. Furthermore, due to a lack of community educa-
tion about proper medical practices, these practitioners
are perceived as being appropriately trained and pa-
tients often prefer injections over other treatment mo-
dalities. In the following sections, we present each of
these themes in detail and discuss the supporting data.
Inappropriate intramuscular injections are the perceived
cause of GF & PIP
Throughout the interviews, participants consistently re-
ported injections as the cause of GF and PIP. Potential
drugs reported as administered IM in the community in-
cluded quinine, penicillin, and gentamycin, with a variety
of others noted much less frequently. Participants re-
ported that quinine was most commonly involved in the
development of GF.
“[Gluteal intramuscular injections given frequently to
children include] …quinine, gentamycin and
penicillin.” (Kumi, Public Nurse)
While participants from both districts reported that
diclofenac, a drug used to treat pain, was primarily ad-
ministered intramuscularly, many reported their belief
that use of diclofenac was unrelated to the develop-
ment of GF and PIP. Several clinicians reported know-
ledge of children receiving diclofenac with no known
complications.
“The only thing I’ve seen being given in the
buttocks [in Wakiso] of late is diclofenac. I’ve not
seen anyone with gluteal fibrosis.” (Wakiso, Private
Physician).
Fig. 1 Theoretical Framework for systems issues contributing to cases of GF and PIP
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The most frequent responses regarding the ways in
which intramuscular injections may lead to health is-
sues suggested that 1) PIP occurs when injections are
administered at the wrong site, close to the sciatic
nerve and 2) GF develops due to infection stemming
from poor sterility practices or necrosis secondary to
toxic medications.
“There is no specific drug, the cause is that the drug is
injected by nonprofessional injecting it in a wrong site
which brings paralysis.” (Wakiso, Public Nurse).
Regarding necrosis causing GF, participants cited in-
correct frequency or dilution during administration in
addition to the toxicity of the drug itself. Specifically,
the frequent dosing of quinine and penicillin injections
subjects children to an excessive number of injections
for a single episode of illness.
“They don’t dilute. It is very toxic to the muscle. In the
healing process of the muscle there is fibrosis.” (Kumi,
Public District Officer).
While the majority of participants felt injections were
the cause of GF and PIP, a few participants suggested
that other factors, in conjunction with injections, might
impact the development of GF and PIP in children.
Some suggested that the geographic distribution of GF
and PIP in Uganda might be explained by a genetic pre-
disposition of the ethnic groups that populate the most
affected regions.
“You see, not everyone [who has intramuscular
injections] gets [gluteal fibrosis]. Maybe it’s something
that these particular children have, either their
healing is compromised…People who get keloids and
have hypertrophic scars that run in families. The
individuals may have a particular risk factors that
make them prone to these disabilities.” (Wakiso,
Private Physician).
Participants highlighted eastern Uganda as a region
where disabilities related to GF and PIP are prevalent.
“Yes I have heard of gluteal fibrosis, in the northeast.”
(Wakiso, Public Village Health Worker).
Other participants expressed concern that GF and PIP
may occur in regions outside of the northeast, but may be
misdiagnosed due to poor knowledge of the conditions.
“The problem is many people don’t know it. Like I
also thought then that it was probably to do with
exaggerated femoral anteversion or retroversion or
something like that…Some of them think it may be a
form of muscular dystrophy. Some of them think it’s
cerebral palsy. It’s being misdiagnosed. The problem
is many people do not know about it.” (Kumi, Private
Physician).
Role of accessibility
While all participants reported a belief that GF and PIP
were directly caused by injections, many went on to
describe the system-level factors contributing to the
inappropriate injection practices. Participants in both
districts described persistent problems with government-
run public health facilities, including frequent shortages
of drugs and a limited number of trained healthcare
workers. These issues, which potential patients consist-
ently encounter at government facilities, can decrease
confidence in the public health system and encourage
patients to seek care at private facilities.
“The number of personnel that are trained is not
enough. There is not a big number, but there are a lot
of people who need care.” (Kumi, Public Pharmacy
Worker).
Filling the gap: Private clinics
Participants cited that these gaps in care are being filled
by private clinics which are often staffed by untrained pro-
fessionals. Private clinics visited by the research team were
run by nursing assistants, lab technicians, and on-the-job
trained staff who discussed how care provision for their
communities included intramuscular injections. Each of
these practitioners described short periods of informal
training without nursing or medical degrees. Per the inter-
viewees, these private clinics are often preferred by pa-
tients as they are more accessible in terms of distance,
cost and time.
“Most of these [private] facilities are run by nursing
assistants or somebody who maybe did some lab work
or somebody who has ever worked at a hospital…They
start up clinics, and they give all those kind of
medications.” (Wakiso, Private Nurse).
Untrained clinicians
The government employed healthcare sector inter-
viewees contend that the untrained or unqualified prac-
titioners working in the private clinics do not have the
knowledge to administer the correct medications nor
skills to deliver appropriate intramuscular and intraven-
ous medications.
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“Some of them might not knowing even the sites [or
sterile techniques], because they are not qualified
personnel.” (Kumi, Public Nurse).
In addition, the subset of government employed par-
ticipants acknowledge that the private clinic workers do
not have access to continuing medical education to learn
current treatment practices because they are not recog-
nized by the government.
“I have attended workshops before when I was
still working at the government hospital; I was
working there and could attend them. Private
clinicians are not invited.” (Wakiso, Private
Local Practitioner).
Misaligned economic incentives
The government employed participants described the
private clinics as profit-run businesses that prefer to
hire lower-cost, untrained clinicians. Additionally, the
government and privately employed participants
pointed out that the private business model motivates
these clinics to provide faster care with “better” cus-
tomer service.
“In those private clinics, they have better customer
care unlike in public hospitals or facilities where
there are lines and you can go and sit there for hours.
In the private clinic they know this is a business. They
know if they don’t give good customer care they lose.”
(Wakiso, Public Community-Based Rehabilitation
Worker).
The pricing of the IM injections may also contribute
to their frequent use. The injections are more profitable
than oral medications, which incentivizes private pro-
viders to administer them, but cost less than the IV medi-
cations, which are often too expensive and time-intensive
for patients and their families.
“…people they can sell [injections] to get more money
than with oral medications.” (Kumi, Private Local
Practitioner).
Inadequate community education
The frequent use of injections is further encouraged by the
lack of education of patients and families regarding practi-
tioners’ qualifications and proper treatment methods. Pa-
tients are largely unable to differentiate between the
public health centers and the private clinics and are
unaware of the lack of training of the practitioners in
the private clinics. Furthermore, many patients also
associate quality with cost of care, believing that the
pricier private clinics provide higher quality of care.
“Then those people don’t have a lot of knowledge to
know that this one is qualified or not. They think
anyone with a white gown is qualified.” (Wakiso,
Public Nurse).
Moreover, interviewees agreed that the community
has developed misconceptions that intramuscular in-
jections are superior to other medical treatments.
Thus, families demand injections for their greater
perceived efficacy.
“They prefer an injection. For most of them, they think
the injections act faster. They think injections get to
the bloodstream faster than tablets.” (Kumi, Public
Physician).
Lack of necessary regulation/enforcement
There was consensus that the proliferation of private
clinics, staffed by untrained professionals, has gone un-
checked due to a lack of regulation and policy enforce-
ment. Interviewees voiced concerns regarding the lack of
district health officials to enforce policies, resulting in
poor monitoring of rural areas.
“Well the laws are there, but the enforcement is poor.”
(Kumi, Public District Officer).
Discussion
This study elicited information from 68 participants
from diverse health care professions and job types re-
garding injection practices and potential risk factors for
GF and PIP in Uganda. The main theme was the percep-
tion that gluteal IM injection practices are the primary
cause of GF and PIP. While prior assessments of the
safety of IM injection practices have focused on rates of
transmission of bloodborne viral pathogens, this study
demonstrates the critical need to consider the risk of
musculoskeletal injury following IM injection, in devel-
oping policies [4, 5, 22].
The interviews documented inadequate training of
personnel giving injections, regardless of medication
delivered, in the incorrect gluteal site as leading to PIP.
This finding is supported by a prior study in Uganda
demonstrating that drugs injected prior to PIP included
quinine, antibiotics, antipyretics and chloroquine [13].
Unfortunately, sciatic nerve injury due to inappropriate
training remains a persistent and global problem with a
need for improvement in education of site selection
[23–25].
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Regarding the pathogenesis of GF, informants per-
ceived that such practices may cause infection and
additionally noted that injection of specific drugs
such as quinine, penicillin and gentamycin may cause
necrosis. The consensus among participants inter-
viewed suggests a focus on sterility and toxicity with
any future research attempting to determine the spe-
cific pathogenesis of GF.
Although IM injection practices might be the direct
cause of GF and PIP, as the theoretical framework illus-
trates, larger health care practice concerns appear to
encourage greater use of the inappropriate injection
practices. As in other resource-limited countries, these
injections are reported to be administered by a variety
of health care practitioners with differing qualifications
and training [4, 5]. The consensus of interviewees was
that unqualified practitioners are administering the IM
injections in private clinics in rural areas. This corrobo-
rates the findings of previous studies demonstrating
that most injections delivered in Uganda were given
by private non-formal providers [22, 26]. The inter-
viewees contend that these private clinics primarily
exist in rural areas, including northeastern Uganda.
This contention corresponds with the findings of this
study, in which 100% of practitioners in rural north-
eastern Kumi district had seen cases of GF and PIP,
while 44 and 67% of practitioners in the urban cen-
tral Wakiso district had seen patients with GF and
PIP, respectively.
The existence of the private clinics with under-
qualified or untrained staff stems from problems with
access, education of the community, misaligned eco-
nomic incentives and lack of policy enforcement. An
informal health sector developed in response to the
gap in the provision of public health care, and the pri-
vate clinics have addressed the excess demand for care
by employing a profit-driven business model which
involves the hiring of a lower-cost untrained work-
force. Furthermore, the public is largely unaware of
the difference in qualifications. Similar development of
an informal, underqualified health sector has occurred in
other resource-limited settings [4]. Compounding these is-
sues is a lack of effective monitoring and regulation, which
allows this informal sector to exist.
Knowledge of these contributing factors cited by prac-
titioners can be utilized to address upstream causes of
GF and PIP, which may have a greater impact for the
population. Interventions to address the current misuse
of injections include improvement in accessibility/health
care delivery, community education on medical treat-
ments and qualifications of clinicians, training of pro-
viders with potential for task shifting and education for
the informal sector, and regulatory actions to support
policy (Table 2).
Limitations for this qualitative analysis include the
focus on two districts in Uganda, which may exclude
potentially relevant practices occurring outside of this
area. In addition, the study’s findings are limited to the
perceptions of the healthcare community. This study
was designed to take place where the disorders are seen
or reported frequently to provide information-rich, ex-
ploratory, and hypothesis-generating data. Given that
IM injections in low-resource countries are a common
and often unnecessary practice, it is essential that injec-
tion practices are addressed [4, 5, 22].
Conclusion
The findings of this study suggest that GF and PIP are
iatrogenic complications of inappropriate intramuscular
injections secondary to upstream healthcare delivery
system limitations. To prevent these musculoskeletal
disorders and the resulting disability, it is important to
address upstream deficits in accessibility, education,
and policy enforcement. The findings from this study
can inform practical interventions that are urgently
needed to address healthcare delivery in Uganda and
thus prevent further cases of GF and PIP.
Table 2 Proposed interventions for improvement of unsafe injection practices
Intervention Examples
Improvement Accessibility/Healthcare Delivery Work with district officers to ensure adequate drug stocks of critically
important medications
Increasing trained/qualified workforce
Regulation/Policy Enforcement Improve control of the sale and use of injection equipment
Enforcement of policy
Education: Providers Carry out continuing medical education programs for all providers on
safe injection practices and treatment guidelines
Train non-formal providers in safe practices
Education: Community Inform public on potential harm of intramuscular injections and
adequacy of oral medications
Sensitize community to qualifications of providers
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Appendix
Table 3 Thematic analysis results with supporting quotations from healthcare and community leader interviews
Kumi Wakiso
Consensus: Inappropriate intramuscular injections are the perceived cause of GF & PIP
• “The outcome has always been attributed to quinine. The mother's
report that on the onset of injection, the child gets paralyzed. The leg
will just be stiff. Others get gluteal fibrosis, failing to squat on knee
bend.” (Kumi, Public Village Health Worker)
• “[Gluteal intramuscular injections given frequently to children include]
…quinine, gentamycin and penicillin.” (Kumi, Public Nurse)
• “[there’s an] epidemic, of intramuscular injections….And quinine itself
was toxic to the muscles. Some of them ended up with a fibrosis
much later because quinine was probably not properly diluted. Not
everyone was giving the correct dilution of quinine for the muscles
so I think there was quinine toxicity in the muscles that led to the
healing by fibrosis.” (Kumi, Private Physician)
• “When penicillin is given IM to children, it causes fibrosis. And as time
goes on sometimes the child gets an abscess…If they hit the wrong
site then the child can develop paralysis.” (Kumi, Public Nurse)
• “Now, if they inject a kid in the buttocks in the wrong position it will
automatically cause that nervous effect in the buttocks and it brings
that paralysis.” (Kumi, Private Nurse)
• “For the paralysis it is mostly due to an injection that is causing a
swelling that compresses the nerve or an injection directly into the
nerve that can cause a paralysis. So, any medicine injected in the
wrong place which targets the nerve can give you a paralysis. What
you’re giving doesn’t matter for the injection… In terms of the
fibrosis, there are a few documented agents or drugs that can cause
tissue necrosis. Something which is less observed or something that
is bound to cause after injection can in the long run cause fibrosis. It
is toxic.” (Kumi, Public Pharmacy Worker)
• “A number of [children with gluteal fibrosis] start by getting an
abscess. And then that abscess will not be managed properly. In the
healing process there is fibrosis.” (Kumi, Public District Officer)
• “So we also need to look at what effect does it have with the
number of different injections. Maybe it is a cumulative effect. Or
there are trigger factors, that when you keep pricking the buttock it
triggers something.” (Kumi, Public District Officer)
• “…in the rural setting, in those clinics, some of them rarely have the
weighing scale…It is guesswork. The weight is guessed….Maybe I
have too high a dose….we have children who have received
injections. Could be the child has fallen sick 3 times in just two
weeks. So when the child goes there they get injections each time.”
(Kumi, Public Nurse)
• “I strongly feel that there’s a causative agent but also host factors
must be responsible because in this region, with this genetic stock of
people, [these disabilities] are quite common around Teso region.
Because I’ve worked in western Uganda, they’ve also given injections,
but we haven’t seen these injections injuries…So, I think [injections
are] a precipitating factor, but there must be host factors…The type
of collagen maybe we have here might be different from the
collagen other people have because in addition to the gluteal
fibrosis, we also see a lot of old men here with urethral stricture
disease, urethral fibrosis…So, there might be a genetic component.
Maybe the collagen.” (Kumi, Private Physician)
• “The problem is many people don’t know it. Like I also thought then
that it was probably to do with exaggerated femoral anteversion or
retroversion or something like that…Some of them think it may be a
form of muscular dystrophy. Some of them think it’s cerebral palsy.
It’s being misdiagnosed. The problem is many people do not know
about it.” (Kumi, Private Physician)
• “The only thing I've seen being given in the buttocks [in Wakiso] of
late is diclofenac. I've not seen anyone with gluteal fibrosis.” (Wakiso,
Private Physician)
• “There is no specific drug, the cause is that the drug is injected by
nonprofessional injecting it in a wrong site which brings paralysis.”
(Wakiso, Public Nurse)
• “They give an injection and it’s not sterile. Sometimes I might find
some kind of infection after injection, and then the formation of
fibrosis.” (Wakiso, Private Local Practitioner)
• “They don’t dilute. It is very toxic to the muscle. In the healing
process of the muscle there is fibrosis.” (Kumi, Public District Officer)
• “Even if you are injected from a normal position, you’re getting 3 - 4
injections in 24 hours times 5 days…” (Wakiso, Public Nurse)
• “You see, not everyone [who has intramuscular injections] gets
[gluteal fibrosis]. Maybe it's something that these particular children
have, either their healing is compromised…People who get keloids
and have hypertrophic scars that run in families. The individuals may
have a particular risk factors that make them prone to these
disabilities.” (Wakiso, Private Physician)
• “The few patients I’ve seen…either they’re coming from the north or
the east. I haven’t seen any patient from Wakiso.” (Wakiso, Private
Nurse)
• “Yes I have heard of gluteal fibrosis, in the northeast.” (Wakiso, Public
Village Health Worker)
Theme 1: There is limited access to healthcare
• “The number of personnel that are trained is not enough. There is
not a big number, but there are a lot of people who need care.”
(Kumi, Public Pharmacy Worker)
• “It is a huge population so [drug stockouts] commonly happen…[The
private clinics] purchase when they need. But for us, we wait. The
government hospitals have to wait for the national medical council
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Table 3 Thematic analysis results with supporting quotations from healthcare and community leader interviews (Continued)
Kumi Wakiso
• “When you go to the hospital, you go in the morning and you come
back in the evening. It is a long distance…Most of them don’t have
that time. You might even come back without treatment.” (Kumi,
Private Drug Shop Worker)
to deliver.” (Wakiso, Public Physician)
Theme 2: Gap in care provision has led to frequent use of private clinics
• “You go to the health unit and they say there are no drugs, go and
buy. So people tend to fill in that gap. So instead of you going very
far, why not just go [to the private clinic]. And then when you go
there you are given things you want.” (Kumi, Public District Officer)
• “In the villages we don’t have trained health workers reaching to
those hard to reach areas, but there are people who need
treatment…So what do they do, they improvise, they find somebody
that can give [them treatment]…You see our country is still primarily
rural. There are so many places that are hard to reach…And you
know whenever there is a gap there is always people that will fill the
gap. So we have a number of private clinics in those hard to reach
areas. They’re actually handled and open by untrained persons.”
(Kumi, Public Pharmacy Worker)
• “So there’s a problem with the health care service provision. There is
no qualified doctor to give the right route of administration in the
rural setting. So these quacks get ahold of this drug and they give
it…People go to the [private] clinics because the distance.” (Kumi,
Private Physician)
• “Most of these [private] facilities are run by nursing assistants or
somebody who maybe did some lab work or somebody who has
ever worked at a hospital…They start up clinics, and they give all
those kind of medications.” (Wakiso, Private Nurse)
Theme 3: The private clinics predominately utilize unqualified clinicians who are not trained to give IM injections
• “In the rural settings…people have gone ahead to open up [private]
clinics, and they are not trained in the techniques on how to inject.
And most of these people end up getting those problems when they
are injected in the clinics.” (Kumi, Public Nurse)
• “There are people masquerading to be nurses and doctors in the
villages who are going to inject. They do it in the wrong sites and
find that kids end up with a problem.” (Kumi, Public Physician)
• “Some of them might not knowing even the sites [or sterile
techniques], because they are not qualified personnel.” (Kumi, Public
Nurse)
• “They say we are failing to get the vein. So let’s inject [the quinine].
But the initial right route is through IV. In the private practice, not all
people are trained, there is a lack of knowledge that they’re supposed
to give IV and some are not trained on how to do it.” (Kumi, Public
District Officer)
• “They are not trained enough. Some of these nurses, they have
difficulty finding the vein and sometimes they may learn how to do
it, but not enough training still. It is easier to give an injection. You
just prick. While finding a vein is difficult.” (Wakiso, Public Village
Health Worker)
• “We have a very serious gap. [We are] good at developing the
policies, launching them, but not dissemination…They are
disseminating the policies mainly to public facilities, leaving these
people from the private facilities without continued education.”
(Wakiso, Public District Officer)
• “I have attended workshops before when I was still working at the
government hospital; I was working there and could attend them.
Private clinicians are not invited.” (Wakiso, Private Local Practitioner)
Theme 4: The private clinics have misaligned economic incentives increasing utilization of IM injections
• “…you cannot place a doctor in the village. How will you pay him,
and do you have enough people to come to that clinic? You resort
to taking these ordinary untrained people, so long as you have
showed him how to treat then they will work there. Of course, the
outcome will be the patient to suffer because the person is not
actually trained.” (Kumi, Public Social Worker)
• “…people they can sell [injections] to get more money than with oral
medications.” (Kumi, Private Local Practitioner)
• “Most of them have an understanding that when you’re given the
injection in the buttock it’s faster [than intravenous]. So when they
are giving injections, the other one is doing a business and gets
more. They give them what they want. They get more business, more
money, more injections.” (Kumi, Public Nurse)
• “In those private clinics, they have better customer care unlike in
public hospitals or facilities where there are lines and you can go and
sit there for hours. In the private clinic they know this is a business.
They know if they don’t give good customer care they lose.” (Wakiso,
Public Community-Based Rehabilitation Worker)
Theme 5: There is inadequate community education regarding appropriate quality healthcare delivery
• “The people in the village cannot distinguish who is a qualified health
person and who is not. So they just go to where they think there is a
service.” (Kumi, Public District Officer)
• “They prefer an injection. For most of them, they think the injections
act faster. They think injections get to the bloodstream faster than
tablets.” (Kumi, Public Physician)
• “Then those people don’t have a lot of knowledge to know that this
one is qualified or not. They think anyone with a white gown is
qualified.” (Wakiso, Public Nurse)
• “People associate quality with money…Where you pay money, the
quality must be better than where it is free, not knowing that the
government is paying.” (Wakiso, Public District Officer)
• “We need continue the campaign on the dangers of giving and
receiving injections. Because in most cases the person that comes in
thinking if you don’t give me an injection I won’t get well.” (Wakiso,
Public Community-Based Rehabilitation Worker)
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